PCRX vs JNJ: Which Stock is Better?
Side-by-side comparison of Pacira BioSciences, Inc. and Johnson & Johnson in 2026
PCRX
Pacira BioSciences, Inc.
—
JNJ
Johnson & Johnson
$267.24
Key Metrics Comparison
| Metric | PCRX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $890.84M | $375.37B | JNJ |
| P/E Ratio | 174.15 | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCRX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCRX or JNJ a better investment?
Comparing PCRX and JNJ: Pacira BioSciences, Inc. has a market cap of $890.84M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCRX and JNJ?
PCRX (Pacira BioSciences, Inc.) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCRX or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (17.4x vs 174.2x).
Which is growing faster: PCRX or JNJ?
Both PCRX and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCRX or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCRX or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $890.84M for PCRX.
Should I buy PCRX or JNJ in 2026?
Both PCRX and JNJ have investment merit. PCRX trades at $N/A while JNJ trades at $267.24. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCRX and JNJ stock?
Key differences: Market Cap ($890.84M vs $375.37B), P/E Ratio (174.2x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCRX or JNJ in 2026?
The choice between PCRX and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCRX and JNJ?
PCRX (Pacira BioSciences, Inc.) has a market cap of $890.84M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.